BioStem Technologies Reports Q2 2026 Financial Results

What Happened

• On August 12, 2026, BioStem Technologies, Inc. announced its financial results for the three and six months ended June 30, 2026 by issuing a press release. The press release was furnished as Exhibit 99.1 to the Form 8-K. The filing was signed by CEO Jason Matuszewski.

Key Details

• Press release date: August 12, 2026.
• Reporting periods covered: three and six months ended June 30, 2026 (Q2 2026 and year-to-date).
• The press release is furnished as Exhibit 99.1 to the Form 8-K and is expressly noted as not being "filed" for purposes of Section 18 of the Exchange Act.
• Form 8-K was signed and dated August 12, 2026 by Jason Matuszewski, Chief Executive Officer.

Why It Matters

• Earnings and quarterly results provide the primary, timely view of a company's recent revenue, profitability and operational trends; this 8-K notifies investors that BioStem’s Q2 and YTD results are now public.
• Retail investors should review the Exhibit 99.1 press release for the detailed financial figures and management commentary, and follow the company’s subsequent periodic filings (such as the Form 10-Q) for complete financial statements and disclosures.